Advisor Group Holdings »

Reneo Pharmaceuticals shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Reneo Pharmaceuticals (RPHM) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Reneo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Reneo Pharmaceuticals held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reneo Pharmaceuticals by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $66 41 1.61
2023-09-30 $762 100 7.62

More positions owned by Advisor Group Holdings

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
NVIDIA Corporation (NVDA)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Total Usd (IUSB)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for Advisor Group Holdings

Top funds holding Reneo Pharmaceuticals

NEA Management Company
Tang Capital Management
Carlyle
RiverVest Venture Management
Octagon Capital Advisors
BML Capital Management
Ikarian Capital
Highbridge Capital Management
Vanguard Group
Aisling Capital Management
Caption Management
Two Sigma Investments
Millennium Management
LMR Partners
GSA Capital Partners

View all funds holding Reneo Pharmaceuticals